Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumab

Abstract

Monoclonal antibodies are typically glycosylated at asparagine residues in the Fc domain, and glycosylation heterogeneity at the Fc sites is well known. This paper presents a method for rapid analysis of glycosylation profile of the therapeutic monoclonal antibody trastuzumab from different production batches using electrospray quadrupole ion-mobility time-of-flight mass spectrometry (ESI-Q-IM-TOF). The global glycosylation profile for each production batch was obtained by a fast LC-MS analysis, and comparisons of the glycoprofiles of trastuzumab from different lots were made based on the deconvoluted intact mass spectra. Furthermore, the heterogeneity at each glycosylation site was characterized at the reduced antibody level and at the isolated glycopeptide level. The glycosylation site and glycan structures were confirmed by performing a time-aligned-parallel fragmentation approach using the unique dual-collision cell design of the instrument and the incorporated ion-mobility separation function. Four different production batches of trastuzumab were analyzed and compared in terms of global glycosylation profiles as well as the heterogeneity at each glycosylation site. The results show that each batch of trastuzumab shares the same types of glycoforms but relative abundance of each glycoforms is varied. (J Am Soc Mass

Profiling ribonucleotide modifications at full-transcriptome level: a step toward MS-based epitranscriptomics

“…As described in previous work, the assignments were confirmed by activating in parallel all species dispersed on the time dimension by the ion mobility element, before transfer to the mass analyzer (Quinn et al 2013). Called time aligned parallel (TAP) dissociation (Damen et al 2009;Castro-Perez et al 2011), this technique provided extensive fragmentation data that matched those observed for the yeast extract in the LTQ-orbitrap determinations. In addition, we explored an alternative characterization strategy that mimicked more traditional tandem MS spectrometry by fragmenting only those species that were recognized as potential PTMs.…”

Evaluation of Ion Mobility-Mass Spectrometry for Comparative Analysis of Monoclonal Antibodies

“…Several studies of large proteins, protein complexes, and protein therapeutics have incorporated IM-MS or CIU IM-MS to determine CCS values [23,[30][31][32][34][35][36][37][38]; however, the suitability of this technique to compare and differentiate protein therapeutics has not yet been evaluated. In this work, we evaluated the suitability of IM-MS and CIU IM-MS measurements for analysis of protein therapeutic systems.…”

Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry

“…For example, characterization of therapeutic mAbs by MS has been applied to product and process development 13,14 and batch consistency assessment. 15 However, MS still needs to be used in concomitance with orthogonal analytical techniques to be able to focus on the different facets of the protein including mainly liquid chromatography (LC). [16][17][18][19][20][21][22] Recently, we described a method using capillary zone electrophoresis (CZE) coupled to tandem MS with a sheathless interface to perform the simultaneous characterization of several aspects of a protein in one injection, including AA sequence and posttranslational modifications (PTMs).…”